Latest Insider Transactions at Navidea Biopharmaceuticals, Inc. (NAVB)
This section provides a real-time view of insider transactions for Navidea Biopharmaceuticals, Inc. (NAVB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NAVIDEA BIOPHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NAVIDEA BIOPHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
John K Scott Jr. |
SELL
Other acquisition or disposition
|
Direct |
2,270
-100.0%
|
-
|
|
Nov 16
2023
|
Dana J Moss |
BUY
Grant, award, or other acquisition
|
Direct |
616,667
+31.62%
|
-
|
|
Nov 16
2023
|
Jill Stefanelli |
BUY
Grant, award, or other acquisition
|
Direct |
691,667
+32.52%
|
-
|
|
Nov 10
2023
|
Craig Dais CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
973,633
+50.0%
|
-
|
|
Jul 11
2023
|
Dana J Moss |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Jun 29
2023
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
12,200,000
+27.76%
|
$0
$0.09 P/Share
|
|
Jun 08
2023
|
Jill Stefanelli |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Jun 05
2023
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
11,508,672
+37.05%
|
-
|
|
Jun 01
2023
|
John K Scott Jr. |
SELL
Other acquisition or disposition
|
Direct |
990
-30.37%
|
-
|
|
Nov 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+1.71%
|
-
|
|
Nov 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+1.81%
|
-
|
|
Nov 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.02%
|
-
|
|
Nov 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.76%
|
-
|
|
Nov 29
2022
|
Joshua M. Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Oct 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.42%
|
-
|
|
Oct 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.62%
|
-
|
|
Oct 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Oct 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.5%
|
-
|
|
Sep 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.53%
|
-
|
|
Sep 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Sep 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.76%
|
-
|
|
Sep 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.54%
|
-
|
|
Sep 09
2022
|
Michael Stanley Rosol Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,150
+29.32%
|
-
|
|
Aug 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.91%
|
-
|
|
Aug 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.67%
|
-
|
|
Aug 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.55%
|
-
|
|
Aug 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Jul 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.57%
|
-
|
|
Jul 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Jul 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.07%
|
-
|
|
Jul 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.81%
|
-
|
|
Jun 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.24%
|
-
|
|
Jun 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.96%
|
-
|
|
Jun 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.6%
|
-
|
|
Jun 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
May 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.13%
|
-
|
|
May 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.43%
|
-
|
|
May 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
May 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.62%
|
-
|
|
Apr 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.31%
|
-
|
|
Apr 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.63%
|
-
|
|
Apr 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.65%
|
-
|
|
Apr 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Apr 10
2022
|
John K Scott Jr. |
BUY
Open market or private purchase
|
Direct |
3,260
+50.0%
|
-
|
|
Mar 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.5%
|
-
|
|
Mar 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.86%
|
-
|
|
Mar 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Mar 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.68%
|
-
|
|
Feb 28
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.71%
|
-
|
|
Feb 28
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.1%
|
-
|